12 Week Nuchal Translucency Scan and Blood Test

There are a number of tests and scans available to you during your pregnancy. The nuchal translucency scan is an ultrasound that may detect the risk of a number of chromosomal abnormalities. A nuchal translucency scan is part of the ultrasound scan that most pregnant women have at around 12 weeks of pregnancy. The results of a nuchal translucency scan may tell you if your baby has a high or low risk of a chromosomal abnormality. Examples of chromosomal abnormalities include trisomy 21 Down syndrome , trisomy 18 Edwards syndrome or trisomy 13 Patau syndrome. The results will tell you if your baby is at high risk or low risk of chromosomal abnormality in comparison to the general population. The nuchal translucency scan is done between 11 and 14 weeks of pregnancy. Usually the scan is done through your abdomen but occasionally the nuchal translucency can only be seen by inserting a probe into the vagina. You might also be offered a blood test around this time. Your doctor can look at the results of the combined test blood test and nuchal translucency scan to get a more accurate picture of the risk of a chromosomal abnormality.

Screening for Down Syndrome

It’s offered to all pregnant women, along with a blood test, in first-trimester combined screening options. The NT scan measures the clear translucent space in the tissue at the back of your baby’s neck. This is the “nuchal translucency.

Ultrasound image of NT measurement. Figure 3. Transvaginal Other specialized ultrasound scans may include a fetal tions without a significant difference in the perinatal accurate means for sonographic dating of pregnancy​. Beyond.

This scan well assess the health of your baby during your first trimester, and identify any issues early in the pregnancy. The nuchal translucency scan is a non-invasive ultrasound procedure usually performed on the abdomen area, although it may also be performed vaginally. This assessment is important as it allows the diagnosis of potential fetal complications including Down syndrome.

If our specialists detect any abnormalities using our state-of-the-art ultrasound technology, we will notify you of the risks and discuss your options. Counselling and recommendations for non-invasive prenatal testing or definitive tests such as amniocentesis or CVS invasive confirmation of chromosomal complications can be offered. The nuchal translucency scan is recommended between 12 and 14 weeks of pregnancy as this is the stage of the pregnancy when the thickness of the nuchal translucency fluid layer is seen differently from chromosomally normal fetuses.

When determining your risk of chromosomal complications there are three main independent risk factors used in the assessment, including:. An assessment of fetal heart including tricuspid regurgitance and blood flow in a fetal vessel-ductus venosus is also used in the decision-making. As well as Down syndrome detection, a nuchal translucency scan may also detect other abnormalities including:. Non invasive prenatal testing NIPT is currently available from 10 weeks for testing of fetal chromosomal abnormalities such as Down syndrome Trisomy 21 , Trisomy 13 and The 12 weeks nuchal translucency scan is still recommended as it will check how the baby is forming structurally, as well as pick up other chromosomal anomalies not detected by the NIPT.

Nuchal Translucency Screening

Obstetric ultrasound, also known as prenatal or pregnancy ultrasound, uses high-frequency sound waves to produce images of a developing embryo or fetus. Your doctor will use information from obstetric ultrasounds to track pregnancy progress, gestational age and help predict delivery dates. During an obstetric ultrasound, you will be on a bed, usually on your back. You may be asked to change position during your scan.

The dating scan is usually attended between 6 and 12 weeks gestation. The nuchal translucency is the name for the normal fluid space.

Thank you for visiting nature. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser or turn off compatibility mode in Internet Explorer. In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Purpose: To assess nuchal translucency measurements that were performed as part of routine prenatal screening for Down syndrome.

Methods: Collect ultrasound measurements of nuchal translucency and crown rump length provided by individual sonographers over a 6-month period to six North American prenatal screening laboratories, along with the laboratory’s nuchal translucency interpretation in multiples of the median. For sonographers with 50 or more observations, compute three nuchal translucency quality measures medians, standard deviations, and slopes , based on epidemiological monitoring.

Results: Altogether, 23, nuchal translucency measurements were submitted by sonographers. Conclusion: Laboratories should routinely monitor the quality of nuchal translucency measurements that are received for incorporation into Down syndrome screening risk calculations and interpretations. When possible, instituting sonographer-specific medians and providing individualized feedback about performance and numbers of women tested offer the potential to yield more consistent and improved performance.

Nuchal translucency NT is defined as the collection of fluid behind the fetal neck occurring in the first trimester of pregnancy.

Nuchal Translucency (NT) Ultrasound

Nuchal translucency NT is the sonographic appearance of a collection of fluid under the skin behind the fetal neck in the first-trimester of pregnancy. The term translucency is used, irrespective of whether it is septated or not and whether it is confined to the neck or envelopes the whole fetus. In fetuses with chromosomal abnormalities, cardiac defects and many genetic syndromes the NT thickness is increased.

The Fetal Medicine Foundation FMF has introduced a process of comprehensive training, support and audit for the proper implementation of early screening for chromosomal abnormalities. The FMF advocates that effective screening requires:. The requirements for obtaining the FMF certificate of competence in the nuchal translucency NT scan are:.

1 – Nuchal translucency scan ( weeks) What is a nuchal translucency scan? Nuchal Translucency is a combined screening test, which involves an Click on the different category headings to find out more and change our default settings. additional information on multiple pregnancy, accurately date your pregnancy.

Now comes the moment when you might get to see your baby for the first time — the week scan. We run through what scans are and what to expect on the day. This is often just called a scan. The scan builds a picture from the way high-frequency sound waves from a probe passed over your tummy reflect off your baby in your womb Whitworth et al, ; NHS, a; NHS, b.

Because of this, the week scan can also be called a dating scan NHS, c. This gives you detailed information about the types of scan offered and what they look for Healthtalk,

Dating scan or NT Scan (routine) at 10-14 weeks

See Appendix 5: Non-invasive prenatal screening for more information. Skip to main content. Indications Dating of pregnancy Early anatomy assessment Detection of multiple pregnancy chorionicity and amnionicity Screening for chromosomal anomalies and other conditions. Required clinical details LMP Any symptoms Previous relevant maternal or family history History of previous caesarean section.

Ultrasound examination TA scan is usually adequate.

12 Week Nuchal Translucency Scan and Blood Test. The week pregnancy ultrasound scan, or nuchal scan, is the first routine scan of pregnancy. You can.

It is usually part of an assessment called combined first trimester screening. Combined first trimester screening assesses the risk for your baby having certain chromosomal abnormalities trisomy 13, 18 and This testing combines the nuchal translucency ultrasound with specific blood tests. Nuchal translucency ultrasound alone can also provide this risk assessment, but it is not as accurate as combined first trimester screening.

For example, it tells us whether your baby has a low risk of having trisomy 13, 18 or 21, or whether your baby has a high risk of having trisomy 13, 18 or This test gives us an indication of whether we should worry about your baby based on these results. Chorionic villus sampling and amniocentesis are invasive tests, involving putting needles into the placenta or amniotic sac, and they are associated with an increased risk of miscarriage.

Nuchal Translucency Ultrasound

They measure a small fluid collection within the skin at the back of the baby’s neck nuchal translucency to help identify the chance of Down’s syndrome and other conditions. If the measurement of the fluid is the same or greater than 3. The chance of a baby having Down’s syndrome increases as the mother gets older. Not everyone we talked to had a nuchal scan.

Sometimes it was not offered locally on the NHS, and some people decided they did not want to pay for it privately, particularly if they felt they had a lower chance of their baby having a condition.

It’s routine to have a dating scan around weeks, to confirm and date the pregnancy. Your baby’s expected date of birth is then calculated.

Learn about our expanded patient care options for your health care needs. Combined first-trimester nuchal translucency screening is a noninvasive screening test for fetal Down syndrome and trisomies 13 and Prenatal genetic counseling services are also provided in conjunction with first-trimester screening, if requested. If you are a health care provider referring your patient to Johns Hopkins for first-trimester screening, learn more here.

Down syndrome and trisomies 13 and 18 are chromosomal disorders that cause intellectual disability and birth defects. Trisomy 18 having an extra 18th chromosome and trisomy 13 having an extra 13th chromosome are more severe disorders that cause profound intellectual disability and severe birth defects in many organ systems.

Few babies with trisomies 13 or 18 survive more than a few months. What can combined first-trimester screening tell me about my pregnancy? Combined first-trimester screening is not a diagnostic test, which means it cannot tell you whether your baby has Down syndrome, trisomy 13 or trisomy Instead, the screening provides a probability that the baby might have Down syndrome, trisomy 13 or trisomy This probability, or chance, is based on three criteria: your age, information obtained on an ultrasound and bloodwork.

We value your feedback

Since chromosomal abnormalities can result in impaired cardiovascular development, a nuchal translucency scan is used as a screening, rather than diagnostic, tool for conditions such as Down syndrome , Patau syndrome , Edwards Syndrome , and non-genetic body-stalk anomaly. There are two distinct measurements: the size of the nuchal translucency and the thickness of the nuchal fold.

Nuchal translucency size is typically assessed at the end of the first trimester, between 11 weeks 3 days and 13 weeks 6 days of pregnancy.

Gestational age is calculated from the first day of the last menstrual period (LMP) or from an earlier ultrasound-dating scan. Please ask the patient to have this.

An ultrasound scan that helps the NHS confirm how many weeks pregnant you are, checks how your baby is developing – and gives you an amazing black and white photo to take home By Rachel Mostyn. They will also check that anatomically everything is where should be. Then you get your amazing pictures and you can tell the world! Not necessarily. Dating scans are offered at some point between 8 and 14 weeks, with most of them happening between 11 and 14 weeks.

As the transducer gets to work, a black-and-white image of your baby will appear on the monitor that the sonographer is looking at. Private providers may offer this earlier, however. In order to get the full results, the findings of the nuchal translucency NT part of your scan need to be combined with the findings of your blood test. You may find that your EDD is quite a few days later or earlier than you thought.

We all are! Even if there is an issue, it may well be something that turns out to be not that serious or something that can be easily managed by the specialists. I was literally having an asthma attack by the time they called me in. But it was great.

Measuring Nuchal Translucency and Crown Rump Length: 12–13 weeks scan